Synthesis and carbonic anhydrase I, II, VII, and IX inhibition studies with a series of benzo[d]thiazole-5- and 6-sulfonamides

Abstract A series of benzo[d]thiazole-5- and 6-sulfonamides has been synthesized and investigated for the inhibition of several human (h) carbonic anhydrase (CA, EC 4.2.1.1) isoforms, using ethoxzolamide (EZA) as lead molecule. 2-Amino-substituted, 2-acylamino- and halogenated (bromo-and iodo-derivatives at the heterocyclic ring) compounds led to several interesting inhibitors against the cytosolic hCA I, II and VII, as well as the transmembrane, tumor-associated hCA IX isoforms. Several subnanomolar/low nanomolar, isoform-selective sulfonamide inhibitors targeting hCA II, VII and IX were detected. The sharp structure–activity relationship for CA inhibition with this small series of derivatives, with important changes of activity observed even after minor changes in the scaffold or at the 2-amino moiety, make this class of scarcely investigated sulfonamides of particular interest for further investigations.

[1]  C. Supuran Advances in structure-based drug discovery of carbonic anhydrase inhibitors , 2017, Expert opinion on drug discovery.

[2]  T. Tunç,et al.  A novel proton transfer salt of 2-amino-6-sulfamoylbenzothiazole and its metal complexes: the evaluation of their inhibition effects on human cytosolic carbonic anhydrases , 2017, Journal of enzyme inhibition and medicinal chemistry.

[3]  C. Supuran,et al.  Benzenesulfonamides Incorporating Flexible Triazole Moieties Are Highly Effective Carbonic Anhydrase Inhibitors: Synthesis and Kinetic, Crystallographic, Computational, and Intraocular Pressure Lowering Investigations. , 2016, Journal of medicinal chemistry.

[4]  C. Supuran,et al.  Carbonic anhydrase inhibition for the management of cerebral ischemia: in vivo evaluation of sulfonamide and coumarin inhibitors , 2016, Journal of enzyme inhibition and medicinal chemistry.

[5]  C. Supuran,et al.  Multicomponent chemistry in the synthesis of carbonic anhydrase inhibitors , 2016, Journal of enzyme inhibition and medicinal chemistry.

[6]  C. Supuran,et al.  Synthesis and bioactivities of halogen bearing phenolic chalcones and their corresponding bis Mannich bases , 2016, Journal of enzyme inhibition and medicinal chemistry.

[7]  C. Supuran,et al.  Overexpression of the transmembrane carbonic anhydrase isoforms IX and XII in the inflamed synovium , 2016, Journal of enzyme inhibition and medicinal chemistry.

[8]  S. Carradori,et al.  Microwave-assisted extraction, HPLC analysis, and inhibitory effects on carbonic anhydrase I, II, VA, and VII isoforms of 14 blueberry Italian cultivars , 2016, Journal of enzyme inhibition and medicinal chemistry.

[9]  I. Gulcin,et al.  Synthesis and carbonic anhydrase inhibitory activities of new thienyl-substituted pyrazoline benzenesulfonamides , 2016, Journal of enzyme inhibition and medicinal chemistry.

[10]  C. Supuran Structure and function of carbonic anhydrases. , 2016, The Biochemical journal.

[11]  C. B. Mishra,et al.  Design, synthesis and biological evaluation of N-(5-methyl-isoxazol-3-yl/1,3,4-thiadiazol-2-yl)-4-(3-substitutedphenylureido) benzenesulfonamides as human carbonic anhydrase isoenzymes I, II, VII and XII inhibitors , 2016, Journal of enzyme inhibition and medicinal chemistry.

[12]  C. Supuran Carbonic anhydrase inhibition and the management of neuropathic pain , 2016, Expert review of neurotherapeutics.

[13]  C. Supuran,et al.  A substituted sulfonamide and its Co (II), Cu (II), and Zn (II) complexes as potential antifungal agents , 2016, Journal of enzyme inhibition and medicinal chemistry.

[14]  C. Supuran,et al.  Isoform-selective inhibitory profile of 2-imidazoline-substituted benzene sulfonamides against a panel of human carbonic anhydrases , 2016, Journal of enzyme inhibition and medicinal chemistry.

[15]  C. Supuran How many carbonic anhydrase inhibition mechanisms exist? , 2016, Journal of enzyme inhibition and medicinal chemistry.

[16]  C. Supuran,et al.  Lansoprazole and carbonic anhydrase IX inhibitors sinergize against human melanoma cells , 2016, Journal of enzyme inhibition and medicinal chemistry.

[17]  C. Supuran Acetazolamide for the treatment of idiopathic intracranial hypertension , 2015, Expert review of neurotherapeutics.

[18]  C. Supuran,et al.  Biochemical characterization of recombinant β-carbonic anhydrase (PgiCAb) identified in the genome of the oral pathogenic bacterium Porphyromonas gingivalis , 2015, Journal of enzyme inhibition and medicinal chemistry.

[19]  C. Supuran,et al.  A class of sulfonamide carbonic anhydrase inhibitors with neuropathic pain modulating effects. , 2015, Bioorganic & medicinal chemistry.

[20]  C. Supuran,et al.  Recent advances in the discovery of zinc-binding motifs for the development of carbonic anhydrase inhibitors , 2015, Journal of enzyme inhibition and medicinal chemistry.

[21]  C. Supuran,et al.  An overview of the alpha-, beta- and gamma-carbonic anhydrases from Bacteria: can bacterial carbonic anhydrases shed new light on evolution of bacteria? , 2015, Journal of enzyme inhibition and medicinal chemistry.

[22]  C. Supuran,et al.  Discovery of a new family of carbonic anhydrases in the malaria pathogen Plasmodium falciparum--the η-carbonic anhydrases. , 2014, Bioorganic & medicinal chemistry letters.

[23]  C. Supuran,et al.  Sulfa and trimethoprim-like drugs – antimetabolites acting as carbonic anhydrase, dihydropteroate synthase and dihydrofolate reductase inhibitors , 2014, Journal of enzyme inhibition and medicinal chemistry.

[24]  C. Supuran,et al.  Exploiting the hydrophobic and hydrophilic binding sites for designing carbonic anhydrase inhibitors , 2013, Expert opinion on drug discovery.

[25]  C. Supuran,et al.  Anticancer carbonic anhydrase inhibitors: a patent review (2008 – 2013) , 2013, Expert opinion on therapeutic patents.

[26]  Andrea Scozzafava,et al.  Antiobesity carbonic anhydrase inhibitors: a literature and patent review , 2013, Expert opinion on therapeutic patents.

[27]  C. Supuran Carbonic anhydrase inhibitors: an editorial , 2013, Expert opinion on therapeutic patents.

[28]  C. Supuran,et al.  Diuretics with carbonic anhydrase inhibitory action: a patent and literature review (2005 – 2013) , 2013, Expert opinion on therapeutic patents.

[29]  C. Supuran,et al.  Antiglaucoma carbonic anhydrase inhibitors: a patent review , 2013, Expert opinion on therapeutic patents.

[30]  C. Supuran Carbonic anhydrases: from biomedical applications of the inhibitors and activators to biotechnological use for CO2 capture , 2013, Journal of enzyme inhibition and medicinal chemistry.

[31]  C. Supuran Structure-based drug discovery of carbonic anhydrase inhibitors , 2012, Journal of enzyme inhibition and medicinal chemistry.

[32]  C. Supuran,et al.  Sulfonamides: a patent review (2008 – 2012) , 2012, Expert opinion on therapeutic patents.

[33]  C. Supuran,et al.  Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms? , 2012, Chemical reviews.

[34]  C. Supuran Carbonic anhydrase inhibitors as emerging drugs for the treatment of obesity , 2012, Expert opinion on emerging drugs.

[35]  C. Supuran,et al.  Dithiocarbamates strongly inhibit carbonic anhydrases and show antiglaucoma action in vivo. , 2012, Journal of medicinal chemistry.

[36]  C. Supuran,et al.  A new approach to antiglaucoma drugs: carbonic anhydrase inhibitors with or without NO donating moieties. Mechanism of action and preliminary pharmacology , 2012, Journal of enzyme inhibition and medicinal chemistry.

[37]  Claudiu T. Supuran,et al.  Interfering with pH regulation in tumours as a therapeutic strategy , 2011, Nature Reviews Drug Discovery.

[38]  C. Supuran,et al.  In Vitro Inhibition of Human Carbonic Anhydrase I and II Isozymes with Natural Phenolic Compounds , 2011, Chemical biology & drug design.

[39]  Vladimir Garaj,et al.  Sulfonamides incorporating 1,3,5-triazine moieties selectively and potently inhibit carbonic anhydrase transmembrane isoforms IX, XII and XIV over cytosolic isoforms I and II: Solution and X-ray crystallographic studies. , 2011, Bioorganic & medicinal chemistry.

[40]  S. Leung,et al.  Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors. , 2011, Cancer research.

[41]  C. Supuran,et al.  Ureido-substituted benzenesulfonamides potently inhibit carbonic anhydrase IX and show antimetastatic activity in a model of breast cancer metastasis. , 2011, Journal of medicinal chemistry.

[42]  C. Supuran,et al.  Selective hydrophobic pocket binding observed within the carbonic anhydrase II active site accommodate different 4-substituted-ureido-benzenesulfonamides and correlate to inhibitor potency. , 2010, Chemical communications.

[43]  Claudiu T. Supuran,et al.  Carbonic anhydrases: novel therapeutic applications for inhibitors and activators , 2008, Nature Reviews Drug Discovery.

[44]  C. Supuran,et al.  Metal-Based Antibacterial and Antifungal Agents: Synthesis, Characterization, and In Vitro Biological Evaluation of Co(II), Cu(II), Ni(II), and Zn(II) Complexes With Amino Acid-Derived Compounds , 2006, Bioinorganic chemistry and applications.

[45]  C. Supuran,et al.  Therapeutic potential of sulfamides as enzyme inhibitors , 2006, Medicinal research reviews.

[46]  Giuseppe Fasolis,et al.  Carbonic anhydrase inhibitors: novel sulfonamides incorporating 1,3,5-triazine moieties as inhibitors of the cytosolic and tumour-associated carbonic anhydrase isozymes I, II and IX. , 2005, Bioorganic & medicinal chemistry letters.

[47]  C. Supuran,et al.  Carbonic anhydrase inhibitors. Inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, IX, and XII with Schiff's bases incorporating chromone and aromatic sulfonamide moieties, and their zinc complexes. , 2005, Bioorganic & medicinal chemistry letters.

[48]  C. Supuran,et al.  Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating 1,2,4-triazine moieties. , 2004, Bioorganic & medicinal chemistry letters.

[49]  Andrea Scozzafava,et al.  Carbonic anhydrase inhibitors. , 2001, Medicinal research reviews.

[50]  Luca Menabuoni,et al.  Carbonic anhydrase inhibitors. A general approach for the preparation of water-soluble sulfonamides incorporating polyamino-polycarboxylate tails and of their metal complexes possessing long-lasting, topical intraocular pressure-lowering properties. , 2002, Journal of medicinal chemistry.

[51]  C. Supuran,et al.  Unsymmetrical 1,1′-disubstituted Ferrocenes: Synthesis of Co(ii), Cu(ii), Ni(ii) and Zn(ii) Chelates of Ferrocenyl -1-thiadiazolo-1′-tetrazole, -1-thiadiazolo-1′-triazole and -1-tetrazolo-1′-triazole with Antimicrobial Properties , 2002, Journal of enzyme inhibition and medicinal chemistry.

[52]  C. Supuran,et al.  Bacterial proteases: current therapeutic use and future prospects for the development of new antibiotics , 2001 .

[53]  A Casini,et al.  Carbonic anhydrase inhibitors: water-soluble 4-sulfamoylphenylthioureas as topical intraocular pressure-lowering agents with long-lasting effects. , 2000, Journal of medicinal chemistry.

[54]  C. Supuran,et al.  Carbonic anhydrase inhibitors: perfluoroalkyl/aryl-substituted derivatives of aromatic/heterocyclic sulfonamides as topical intraocular pressure-lowering agents with prolonged duration of action. , 2000, Journal of medicinal chemistry.

[55]  C. Supuran,et al.  Carbonic anhydrase inhibitors: synthesis of water-soluble, topically effective intraocular pressure lowering aromatic/heterocyclic sulfonamides containing 8-quinoline-sulfonyl moieties: is the tail more important than the ring? , 1999, Bioorganic & medicinal chemistry.

[56]  C. Supuran,et al.  Carbonic anhydrase inhibitors. Synthesis of water-soluble, topically effective, intraocular pressure-lowering aromatic/heterocyclic sulfonamides containing cationic or anionic moieties: is the tail more important than the ring? , 1999, Journal of medicinal chemistry.

[57]  C. Supuran,et al.  Carbonic anhydrase inhibitors - Part 57 : Quantum chemical QSAR of a group of 1,3,4-thiadiazole- and 1,3,4-thiadiazoline disulfonamides with carbonic anhydrase inhibitory properties , 1999 .

[58]  C. Supuran,et al.  Carbonic anhydrase inhibitors — Part 52. Metal complexes of heterocyclic sulfonamides: A new class of strong topical intraocular pressure-lowering agents in rabbits , 1998 .

[59]  C. Supuran,et al.  Carbonic anhydrase inhibitors - Part 49: Synthesis of substituted ureido and thioureido derivatives of aromatic/heterocyclic sulfonamides with increased affinities for isozyme I , 1998 .

[60]  C. Supuran,et al.  Carbonic Anhydrase Activators. Part 14. Syntheses of Mono- and Bis( pyridinium)salt Derivatives of 2-Amino-5-(2-aminoethyl)- and 2-Amino-5- (3-aminopropyl)-1,3,4-thiadiazole and Their Interaction with Isozyme II. , 1996 .

[61]  C. Supuran,et al.  Carbonic anhydrase inhibitors. Part 35. Synthesis of Schiff bases derived from sulfanilamide and aromatic aldehydes: the first inhibitors with equally high affinity towards cytosolic and membrane-bound isozymes* , 1996 .

[62]  C. Supuran,et al.  Carbonic anhydrase inhibitors. Part 37. Novel classes of isozyme I and II inhibitors and their mechanism of action. Kinetic and spectroscopic investigations on native and cobalt-substituted enzymes# , 1996 .

[63]  C. Supuran,et al.  Carbonic anhydrase activators. 3: structure-activity correlations for a series of isozyme II activators. , 1994, Journal of pharmaceutical sciences.

[64]  R. Khalifah,et al.  The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C. , 1971, The Journal of biological chemistry.